Crowdonomics
nView medical

Reg CF · Common Stock · Mar 2025

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$160.8K / $399.9K max
40% of ceiling
Investors
156
$1.6K avg
Post-money valuation
$30.2M
pre-money + amount raised

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$247K
−$1.7M
FY2022
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$247,219
—
Cost of goods sold
$123,498
—
Gross margin
50%
—
Net income
-$1,669,253
—
Taxes paid
$0
—
Balance sheet
Cash
$170,783
—
Accounts receivable
$49,442
—
Total assets
$1,019,696
—
Short-term debt
$1,537,297
—
Long-term debt
$4,728,040
—
Total liabilities
$6,265,337
—
Other
Headcount
—
5

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

2 amendments
  1. Jun 23, 2025
    • Deadline Jun 24, 2025 → Aug 28, 2025

    “The issuer is extending their campaign end date to August 28th, 2025.”

    Form C/A on EDGAR ↗
  2. Apr 17, 2025
    No change to filed terms

    “Added disclaimers on future expansion, historical sales, and testimonials.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$30M
Post-money$30.2M
Price / share$8.31
Shares offered14,921

Perks

Early Bird 1: 15% bonus shares · until Mar 26, 202515% bonus
Early Bird 2: 10% bonus shares · until Mar 27, 202510% bonus
Early Bird 4: 3% bonus shares · until Apr 8, 20253% bonus
First 2 Weeks | $15k: $15,000+ · 15% bonus shares · until Apr 8, 202515% bonus$15K+
First 2 Weeks | $10k: $10,000+ · 13% bonus shares · until Apr 8, 202513% bonus$10K+
First 2 Weeks | $5k: $5,000+ · 10% bonus shares · until Apr 8, 202510% bonus$5K+
First 2 Weeks | $1k: $1,000+ · 5% bonus shares · until Apr 8, 20255% bonus$1K+
— 2% bonus shares2% bonus$1K+
— 5% bonus shares5% bonus$5K+
— 8% bonus shares8% bonus$10K+
— 12% bonus shares12% bonus$20K+
— 15% bonus shares15% bonus$30K+

Offering details

Target$123,994
Max$399,935
Min investment—
OpenedMar 26, 2025
DeadlineAug 28, 2025
ClosedAug 28, 2025
Days active155

Links & provenance

Source: SEC EDGAR
0001665160-25-000487
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.